Rianlon Corp (300596) - Total Liabilities
Based on the latest financial reports, Rianlon Corp (300596) has total liabilities worth CN¥5.58 Billion CNY (≈ $816.95 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Rianlon Corp - Total Liabilities Trend (2011–2025)
This chart illustrates how Rianlon Corp's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Rianlon Corp to evaluate short-term liquidity relative to the company's equity base.
Rianlon Corp Competitors by Total Liabilities
The table below lists competitors of Rianlon Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BlackRock Capital Allocation Trust
NYSE:BCAT
|
USA | $370.43 Million |
|
Innuovo Technology Co Ltd Class A
SHE:000795
|
China | CN¥1.50 Billion |
|
Sanbo Hospital Management Group Ltd. A
SHE:301293
|
China | CN¥1.06 Billion |
|
S-1 Corp
KO:012750
|
Korea | ₩668.35 Billion |
|
CCL Products (India) Limited
NSE:CCL
|
India | Rs19.82 Billion |
|
Despegar.com Corp
NYSE:DESP
|
USA | $999.20 Million |
|
Jiangyin Hengrun Heavy
SHG:603985
|
China | CN¥2.57 Billion |
|
Wangfujing
SHG:600859
|
China | CN¥19.44 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Rianlon Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300596 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Rianlon Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Rianlon Corp (2011–2025)
The table below shows the annual total liabilities of Rianlon Corp from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥5.53 Billion ≈ $809.65 Million |
+25.52% |
| 2024-12-31 | CN¥4.41 Billion ≈ $645.03 Million |
+12.06% |
| 2023-12-31 | CN¥3.93 Billion ≈ $575.61 Million |
+7.63% |
| 2022-12-31 | CN¥3.65 Billion ≈ $534.80 Million |
+23.82% |
| 2021-12-31 | CN¥2.95 Billion ≈ $431.91 Million |
+80.74% |
| 2020-12-31 | CN¥1.63 Billion ≈ $238.97 Million |
+34.73% |
| 2019-12-31 | CN¥1.21 Billion ≈ $177.37 Million |
+32.01% |
| 2018-12-31 | CN¥918.22 Million ≈ $134.36 Million |
+61.23% |
| 2017-12-31 | CN¥569.52 Million ≈ $83.34 Million |
+42.95% |
| 2016-12-31 | CN¥398.39 Million ≈ $58.30 Million |
+72.14% |
| 2015-12-31 | CN¥231.43 Million ≈ $33.87 Million |
+6.29% |
| 2014-12-31 | CN¥217.74 Million ≈ $31.86 Million |
-0.51% |
| 2013-12-31 | CN¥218.86 Million ≈ $32.03 Million |
+31.77% |
| 2012-12-31 | CN¥166.09 Million ≈ $24.30 Million |
+33.30% |
| 2011-12-31 | CN¥124.60 Million ≈ $18.23 Million |
-- |
About Rianlon Corp
Rianlon Corporation provides anti-aging additives and application technologies for polymer materials industry in China and internationally. The company's products include primary antioxidants, secondary antioxidants, UV absorbers, HALS, u-pack, polymerization inhibitors, intermediates, light stabilizers, compound customized products, lubricant additives, cosmetics, and life sciences. Its products… Read more